Medication info

Dapahelsun Tablet 10 mg (Dapagliflozin Anhydrous Mixture)

Prescription medicationTabletOralExpired
Ingredient · strength
Dapagliflozin Anhydrous Lactose Mixture›15.27mg / 1 tablet
Manufacturer / importer
Ellison Pharmaceuticals Co., Ltd.
Appearance
Yellow, convex diamond-shaped film-coated tablet
Packaging
28 tablets/box [14 tablets/PTP x 2, 7 tablets/PTP x 4]
Approval status
Expired

MFDS item code 202005375 · Approved 2020.07.23

This product's status changed to Expired on 2025.07.23. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults · Children
Adult dose
Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this drug is 10mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, such as insulin. When this drug is used in combination with insulin or an insulin secretagogue such as a sulfonylurea, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients who have not previously received pharmacological treatment for diabetes, when this drug is administered in combination with metformin, the recommended initial dose is 5mg once daily or 10mg once daily. Special populations Renal impairment - eGFR below 45 mL/min/1.73m2: Administration of this drug is not recommended for the purpose of improving glycemic control. - Patients on dialysis: Do not administer this drug. Hepatic impairment No dose adjustment is required in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, 5 mg is recommended as the starting dose. If well tolerated, this dose may be increased to 10mg. Elderly patients (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This drug may be administered orally once daily at any time of day, with or without food. The tablet should be swallowed whole.
Child dose
The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.

Ingredients

Manufacturer
Ellison Pharmaceuticals Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

  • Type 2 diabetes
  • blood sugar control disorders
  • cardiovascular disease
  • cardiovascular risk factors
View approved original text

This drug is used in conjunction with dietary and exercise recommendations to help control blood sugar levels in patients with type 2 diabetes. It can be used alone or in combination with other medications. In particular, it can help prevent the occurrence of cardiovascular events in patients whose blood sugar is not adequately controlled and who have cardiovascular disease or risk factors. For more information, please refer to professional instructions. This drug is effectively used for the treatment of type 2 diabetes.

How to take

Adult dose

Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this drug is 10mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, such as insulin. When this drug is used in combination with insulin or an insulin secretagogue such as a sulfonylurea, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients who have not previously received pharmacological treatment for diabetes, when this drug is administered in combination with metformin, the recommended initial dose is 5mg once daily or 10mg once daily. Special populations Renal impairment - eGFR below 45 mL/min/1.73m2: Administration of this drug is not recommended for the purpose of improving glycemic control. - Patients on dialysis: Do not administer this drug. Hepatic impairment No dose adjustment is required in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, 5 mg is recommended as the starting dose. If well tolerated, this dose may be increased to 10mg. Elderly patients (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This drug may be administered orally once daily at any time of day, with or without food. The tablet should be swallowed whole.

Child dose

The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.

Precautions

This drug should not be used in patients who have had an allergic reaction to the active ingredient or excipients. It should also not be administered to patients with type 1 diabetes or diabetic ketoacidosis. Moreover, patients with issues related to lactose breakdown, certain genetic disorders, and those on dialysis should not use this drug. It should be administered cautiously to patients with reduced fluid volume or impaired kidney function, as hypotension or changes in kidney function may occur. Patients allergic to the dyes Yellow No. 4 and Yellow No. 5 should also be careful. This drug may increase the risk of genital infections and urinary tract infections, and immediate treatment should be sought if symptoms of infection appear. Because of the risk of hypoglycemia, dosage adjustments may be necessary when used in combination with medications that cause hypoglycemia, such as insulin or sulfonylureas. Symptoms of dehydration or hypotension may occur due to reduced fluid volume, so caution is necessary, particularly for older adults or patients on diuretics. This drug may cause a serious metabolic condition called diabetic ketoacidosis; consult healthcare professionals immediately if related symptoms occur. It is recommended that pregnant or breastfeeding women do not use this drug. The safety and effectiveness of this drug in children or adolescents have not been established, so caution is advised. There is no specific antidote in case of overdose, and appropriate treatment should be provided based on symptoms. This drug does not significantly affect driving or machine operation, but caution should be exercised due to the possibility of hypoglycemic symptoms. This drug must be kept out of the reach of children, and it is safest to store it in its original container.

Side effects

  • Vulvovaginitis
  • balanitis
  • genital infection
  • urinary tract infection
  • fungal infection
  • perineal necrosis
  • hypoglycemia
  • decreased fluid volume
  • thirst
  • diabetic ketoacidosis
Show 132 more
  • dizziness
  • constipation
  • dry mouth
  • lumbar pain
  • pain during urination
  • polyuria
  • nocturia
  • interstitial nephritis
  • vulvar pruritus
  • genital itching
  • increased hematocrit
  • decreased renal creatinine clearance
  • dyslipidemia
  • elevated blood creatinine
  • elevated blood urea
  • weight loss
  • acute pyelonephritis
  • rash
  • angioedema
  • asthenia
  • pain
  • keratitis
  • chronic obstructive pulmonary disease
  • hemoptysis
  • cerebral hemorrhage
  • peripheral artery occlusion
  • angina
  • myocardial infarction
  • biliary calculi
  • cholangitis
  • alcoholic liver cirrhosis
  • depression
  • suicide attempt
  • gastric adenocarcinoma
  • anaphylactic reaction
  • paresthesia
  • cerebral infarction
  • nerve compression
  • sinusitis
  • diverticulitis
  • pelvic inflammatory disease
  • pneumonia
  • pulmonary tuberculosis
  • chest pain
  • ligament sprain
  • hair loss
  • dermatitis
  • xerosis
  • allergic dermatitis
  • contact dermatitis
  • diabetic foot ulcer
  • hyperhidrosis eczema
  • nummular dermatitis
  • eczema
  • hyperkeratosis
  • nail pigmentation
  • skin lesions
  • urticaria
  • diaphoresis
  • flank pain
  • fibromyalgia
  • limb discomfort
  • muscle cramps
  • musculoskeletal discomfort
  • osteopenia
  • contusion
  • road traffic accident
  • drug overdose
  • ankle fracture
  • orbital fracture
  • foot fracture
  • gastrointestinal foreign body
  • hand fracture
  • pelvic fracture
  • laceration
  • ligament rupture
  • limb injury
  • meniscus injury
  • skin abrasion
  • tendon rupture
  • thoracic vertebra fracture
  • tibia fracture
  • dental injury
  • dry eye
  • ocular pain
  • retinal disorder
  • vision loss
  • blepharitis
  • cataract
  • conjunctival edema
  • allergic conjunctivitis
  • conjunctivitis
  • diplopia
  • eyelid edema
  • high intraocular pressure
  • visual impairment
  • vitreous floaters
  • oropharyngeal pain
  • allergic rhinitis
  • asthma
  • speech disorders
  • epistaxis
  • sleep apnea syndrome
  • wheezing
  • atherosclerosis
  • flushing
  • peripheral coldness
  • varicose veins
  • vascular headache
  • orthostatic hypotension
  • atrial fibrillation
  • diastolic dysfunction
  • anxiety disorder
  • nocturia
  • auditory hallucinations
  • sleep disorders
  • insomnia
  • fatty liver
  • gallbladder polyp
  • dizziness
  • tinnitus
  • vaginal discharge
  • menstrual irregularities
  • itching
  • arthralgia
  • musculoskeletal pain
  • limb pain
  • muscle weakness
  • myalgia
  • osteoarthritis
  • palpitations
  • vaginal discharge

Not everyone experiences these, and they can vary from person to person.

Storage

This drug should be stored in a tightly closed container to avoid exposure to air or moisture, ideally at room temperature between 1 to 30 degrees Celsius. This way, the effectiveness of the drug can be maintained for a longer period.

Appearance and packaging

Appearance

Yellow, convex diamond-shaped film-coated tablet

Package unit

28 tablets/box [14 tablets/PTP x 2, 7 tablets/PTP x 4]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.